RGLS $0.00 ( +0.00%) Quote details

stock

Regulus Therapeutics Inc

NASDAQ | RGLS

7.98

USD

+0.00 ( +0.00%)

AT CLOSE (AS OF Apr 30, 2025)

$235M

MARKET CAP

-

P/E Ratio

-0.82

EPS

$3.7

52 Week High

$0.83

52 Week Low

LIFE SCIENCES

Sector

RGLS Chart

1D
Area

Trade Smarter

Automate your trading workflow with powerful tools — built for serious traders.

Icon For Time-schedule

Backtests

Strategy Backtester designed to automate your backtesting and revolutionize the way you trade

Icon For Search

Scanner

Leverage the power of AI to detect valuable opportunities and gain the most out of the markets.

Signals

Automate your trading workflow with AI-powered trading signals to execute trades automatically.

Icon For Clipboard-list

Journal

Record your trades and performance to improve your trading with AfterPullback’s Trading Journal

RGLS Technicals

Tags:

RGLS Earnings

Yearly Income Statement (As of Dec 31, 2024)

Field Value (USD)
Gross Profit -
Total Revenue $0
Cost Of Revenue -
Costof Goods And Services Sold -
Operating Income -$50M
Selling General And Administrative $15M
Research And Development $35M
Operating Expenses $50M
Investment Income Net -
Net Interest Income $3.7M
Interest Income $3.8M
Interest Expense $158K
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization $347K
Income Before Tax -$46M
Income Tax Expense $1K
Interest And Debt Expense -
Net Income From Continuing Operations -$46M
Comprehensive Income Net Of Tax -
Ebit -$46M
Ebitda -$46M
Net Income -$46M

Revenue & Profitability

Earnings Performance

RGLS Financials

yearly Balance Sheet (As of Dec 31, 2024)

Field Value (USD)
Total Assets $84M
Total Current Assets $82M
Cash And Cash Equivalents At Carrying Value $39M
Cash And Short Term Investments $39M
Inventory -
Current Net Receivables -
Total Non Current Assets $1.8M
Property Plant Equipment -
Accumulated Depreciation Amortization Ppe -
Intangible Assets $25K
Intangible Assets Excluding Goodwill $25K
Goodwill -
Investments -
Long Term Investments -
Short Term Investments $37M
Other Current Assets $6.6M
Other Non Current Assets -
Total Liabilities $7.8M
Total Current Liabilities $7.5M
Current Accounts Payable $947K
Deferred Revenue -
Current Debt -
Short Term Debt -
Total Non Current Liabilities $274K
Capital Lease Obligations $274K
Long Term Debt -
Current Long Term Debt -
Long Term Debt Noncurrent -
Short Long Term Debt Total $274K
Other Current Liabilities $6.6M
Other Non Current Liabilities -
Total Shareholder Equity $76M
Treasury Stock -
Retained Earnings -$560M
Common Stock $66K
Common Stock Shares Outstanding $56M

yearly Cash Flow (As of Dec 31, 2024)

Field Value (USD)
Operating Cashflow -$42M
Payments For Operating Activities -
Proceeds From Operating Activities -
Change In Operating Liabilities -
Change In Operating Assets -
Depreciation Depletion And Amortization -$1.2M
Capital Expenditures $340K
Change In Receivables -
Change In Inventory -
Profit Loss -
Cashflow From Investment -
Cashflow From Financing $92M
Proceeds From Repayments Of Short Term Debt -
Payments For Repurchase Of Common Stock -
Payments For Repurchase Of Equity -
Payments For Repurchase Of Preferred Stock -
Dividend Payout -
Dividend Payout Common Stock -
Dividend Payout Preferred Stock -
Proceeds From Issuance Of Common Stock -
Proceeds From Issuance Of Long Term Debt And Capital Securities Net -
Proceeds From Issuance Of Preferred Stock -
Proceeds From Repurchase Of Equity -$69K
Proceeds From Sale Of Treasury Stock -
Change In Cash And Cash Equivalents -
Change In Exchange Rate -
Net Income -$46M

yearly Income Statement (As of Dec 31, 2024)

Field Value (USD)
Gross Profit -
Total Revenue $0
Cost Of Revenue -
Costof Goods And Services Sold -
Operating Income -$50M
Selling General And Administrative $15M
Research And Development $35M
Operating Expenses $50M
Investment Income Net -
Net Interest Income $3.7M
Interest Income $3.8M
Interest Expense $158K
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization $347K
Income Before Tax -$46M
Income Tax Expense $1K
Interest And Debt Expense -
Net Income From Continuing Operations -$46M
Comprehensive Income Net Of Tax -
Ebit -$46M
Ebitda -$46M
Net Income -$46M

RGLS News

RGLS Profile

Regulus Therapeutics Inc Profile

Sector: LIFE SCIENCES

Industry: PHARMACEUTICAL PREPARATIONS

Regulus Therapeutics Inc., a clinical-stage biopharmaceutical company, is dedicated to the discovery and development of drugs that target microRNAs to treat a variety of diseases in the United States. The company is headquartered in San Diego, California.

DMN
97.37%
$0.0075
LGMK
6.75%
$0.0174
PTPI
-7.69%
$0.012
GNLN
5.83%
$0.0127
WW
5.25%
$0.7704
AMCR
-1.18%
$9.22
NVDA
-0.09%
$108.92
PLUG
-5.96%
$0.9592
SNAP
-12.54%
$7.95
F
1.30%
$10.15
TSLA
-3.38%
$282.16
PLTR
2.03%
$118.44
SMCI
-11.50%
$31.86
JFBR
75.29%
$1.49
SOFI
-5.73%
$12.51
AGMH
2.25%
$0.1047
LCID
1.19%
$2.56
AAL
0.51%
$9.95
INTC
-1.18%
$20.1
DNN
0.35%
$1.425
NVNI
37.51%
$0.213
LYT
-16.78%
$0.0982
BTE
-4.06%
$1.535
AMZN
-1.58%
$184.42
JBLU
4.31%
$4.36
AAPL
0.61%
$212.5
GCTK
1.05%
$0.1732
RIG
-3.41%
$2.125
BTG
0.65%
$3.12
RIVN
2.71%
$13.66
ABEV
2.01%
$2.54
BBD
1.03%
$2.455
WLDS
50.00%
$1.8
HOOD
-0.53%
$49.11
DGLY
-6.10%
$0.0354
PFE
2.59%
$24.4065
LYG
-0.88%
$3.945
GRAB
1.88%
$4.88
SBUX
-5.66%
$80.05
WBD
-1.14%
$8.67
HIMS
-5.62%
$33.07
BAC
-0.35%
$39.85
NGD
18.81%
$3.98
MARA
1.50%
$14.22
EJH
-45.51%
$0.4251
GOOGL
-0.85%
$158.8
MSFT
0.31%
$395.26
NCLH
-7.83%
$16.02
NIO
-4.72%
$4.04
RIOT
-2.43%
$7.24
VRN
-2.87%
$5.915
CCL
-0.80%
$18.71
VALE
-3.13%
$9.3
ME
-21.26%
$0.6063
CUTR
-10.19%
$0.0969
VZ
2.58%
$44.06
AGNC
-2.65%
$8.83
RGLS
136.80%
$7.98
ACHR
-7.56%
$8.31
STEM
29.78%
$0.5386
FRGT
24.05%
$1.24
TLRY
-0.96%
$0.4851
APLD
-4.88%
$4.48
META
-0.98%
$549
HL
-1.38%
$5.72
WULF
-4.79%
$2.78
T
0.15%
$27.3
ITUB
-0.08%
$6.305
WFC
2.41%
$71.1
ERIC
-0.78%
$8.235
PCG
-4.84%
$16.51
AMD
1.43%
$97.43
AZUL
-11.38%
$0.7444
VOD
1.88%
$9.76
AVGO
0.68%
$192.47
SLB
-2.55%
$33.24
PBR
-2.04%
$11.285
KO
0.26%
$72.535
GOOG
-0.72%
$160.89
XOM
-2.58%
$105.56
QBTS
-1.36%
$6.905
MU
0.09%
$76.95
FNA
0.00%
$13.09
STSS
12.20%
$5.61
IQ
-2.13%
$1.84
BON
-8.97%
$0.066
BERY
-2.93%
$67.58
CLSK
-1.52%
$8.44
ET
-3.08%
$16.515
ABEO
23.77%
$6.56
HPE
-0.55%
$16.22
HBAN
-0.75%
$14.53
KGC
1.17%
$14.76
BCS
-0.47%
$16.055
AES
-3.62%
$9.995
FSM
2.88%
$6.245
GM
-3.69%
$45.21
HLN
-1.26%
$10.15
NKE
-2.00%
$56.39
PTEN
-5.21%
$5.64
DMN
97.37%
$0.0075
LGMK
6.75%
$0.0174
PTPI
-7.69%
$0.012
GNLN
5.83%
$0.0127
WW
5.25%
$0.7704
AMCR
-1.18%
$9.22
NVDA
-0.09%
$108.92
PLUG
-5.96%
$0.9592
SNAP
-12.54%
$7.95
F
1.30%
$10.15
TSLA
-3.38%
$282.16
PLTR
2.03%
$118.44
SMCI
-11.50%
$31.86
JFBR
75.29%
$1.49
SOFI
-5.73%
$12.51
AGMH
2.25%
$0.1047
LCID
1.19%
$2.56
AAL
0.51%
$9.95
INTC
-1.18%
$20.1
DNN
0.35%
$1.425
NVNI
37.51%
$0.213
LYT
-16.78%
$0.0982
BTE
-4.06%
$1.535
AMZN
-1.58%
$184.42
JBLU
4.31%
$4.36
AAPL
0.61%
$212.5
GCTK
1.05%
$0.1732
RIG
-3.41%
$2.125
BTG
0.65%
$3.12
RIVN
2.71%
$13.66
ABEV
2.01%
$2.54
BBD
1.03%
$2.455
WLDS
50.00%
$1.8
HOOD
-0.53%
$49.11
DGLY
-6.10%
$0.0354
PFE
2.59%
$24.4065
LYG
-0.88%
$3.945
GRAB
1.88%
$4.88
SBUX
-5.66%
$80.05
WBD
-1.14%
$8.67
HIMS
-5.62%
$33.07
BAC
-0.35%
$39.85
NGD
18.81%
$3.98
MARA
1.50%
$14.22
EJH
-45.51%
$0.4251
GOOGL
-0.85%
$158.8
MSFT
0.31%
$395.26
NCLH
-7.83%
$16.02
NIO
-4.72%
$4.04
RIOT
-2.43%
$7.24
VRN
-2.87%
$5.915
CCL
-0.80%
$18.71
VALE
-3.13%
$9.3
ME
-21.26%
$0.6063
CUTR
-10.19%
$0.0969
VZ
2.58%
$44.06
AGNC
-2.65%
$8.83
RGLS
136.80%
$7.98
ACHR
-7.56%
$8.31
STEM
29.78%
$0.5386
FRGT
24.05%
$1.24
TLRY
-0.96%
$0.4851
APLD
-4.88%
$4.48
META
-0.98%
$549
HL
-1.38%
$5.72
WULF
-4.79%
$2.78
T
0.15%
$27.3
ITUB
-0.08%
$6.305
WFC
2.41%
$71.1
ERIC
-0.78%
$8.235
PCG
-4.84%
$16.51
AMD
1.43%
$97.43
AZUL
-11.38%
$0.7444
VOD
1.88%
$9.76
AVGO
0.68%
$192.47
SLB
-2.55%
$33.24
PBR
-2.04%
$11.285
KO
0.26%
$72.535
GOOG
-0.72%
$160.89
XOM
-2.58%
$105.56
QBTS
-1.36%
$6.905
MU
0.09%
$76.95
FNA
0.00%
$13.09
STSS
12.20%
$5.61
IQ
-2.13%
$1.84
BON
-8.97%
$0.066
BERY
-2.93%
$67.58
CLSK
-1.52%
$8.44
ET
-3.08%
$16.515
ABEO
23.77%
$6.56
HPE
-0.55%
$16.22
HBAN
-0.75%
$14.53
KGC
1.17%
$14.76
BCS
-0.47%
$16.055
AES
-3.62%
$9.995
FSM
2.88%
$6.245
GM
-3.69%
$45.21
HLN
-1.26%
$10.15
NKE
-2.00%
$56.39
PTEN
-5.21%
$5.64
Discover more tools and features to empower your trading
Explore Features

Quotes and other market data may be delayed by 15 minutes or more. Financial data is provided by financial exchanges and other content providers and may be delayed as specified by financial exchanges or other data providers. AfterPullback does not verify any data and disclaims any obligation to do so. The information contained on this website is not intended as, and shall not be understood as, financial advice. The website does not operated by attorney, accountant or financial advisor and the information contained on this website is not a substitute for financial advice from a professional who is aware of the facts and circumstances of your individual situation. Nothing available on or through this website should be understood as a recommendation that you should not consult with a financial professional to address your particular information.